Immunization, Vaccines and Biologicals
The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy.
HIV
Introduction
Human immunodeficiency virus (HIV) is an infection that attacks the body’s immune system, specifically the white blood cells called CD4 cells. HIV destroys these CD4 cells, weakening a person’s immunity against opportunistic infections, such as tuberculosis and fungal infections, severe bacterial infections and some cancers.
For more on HIV, please visit:
IVB's Product and Delivery Research (PDR) unit works in collaboration with partners to accelerate the development and availability of safe, effective and affordable HIV vaccines and monoclonal antibodies (mAbs). PDR has published Preferred Product Characteristics for monoclonal antibodies for HIV prevention.
It is a priority for WHO to ensure that products are developed in a manner that supports optimal use globally, including in low- and middle-income countries...
Vaccine and mAbs pipeline
For information on the HIV vaccine and mAb pipeline, see the links below:
WHO meetings